Groman Dan's Form 4 filing
Enfusion, Inc. (ENFN) · filed Aug 11, 2023
- Accession no.
- 0001104659-23-090487
- Filed
- Aug 11, 2023
- Trade date
- Aug 9-10, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $17.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Groman DanCIK 0001881296 | Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | Class A Common Stock | AGrant or awardAcquired | +4,855 | $0.00 | $0 | 116,638 | Direct | |
| Aug 10, 2023 | Class A Common Stock | SSaleDisposed | −2,106 | $8.08 | −$17,016.48 | 114,532 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.